- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Carcinoma, Ovarian Epithelial in United Kingdom
Total 14592 results
-
University of California, IrvinePatient-Centered Outcomes Research InstituteCompleted
-
University of British ColumbiaGenzyme, a Sanofi CompanyTerminatedEpithelial Ovarian CancerCanada, United States
-
University of OklahomaCompletedOvarian CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Jeanne Drisko, MD, CNS, FACNUniversity of Kansas Medical Center; Cancer Treatment Research FoundationCompleted
-
University of IowaTerminatedOvarian CancerUnited States
-
Loyola UniversityCelgene CorporationWithdrawnOvarian CancerUnited States
-
National Cancer Institute (NCI)CompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Daiichi Sankyo, Inc.CompletedOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVUnited States
-
Hoffmann-La RocheCompletedOvarian CancerBelgium, Spain, Canada, Russian Federation, United Kingdom, Hungary, Italy, Poland, Netherlands
-
Astellas Pharma IncAgensys, Inc.CompletedCarcinoma | Ovarian Diseases | Ovarian Neoplasms | Ovarian CancerUnited States
-
University of WashingtonCompletedOvarian CancerUnited States
-
NYU Langone HealthCompletedOvarian CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Dana-Farber Cancer InstitutePatty Brisben Foundation For Women's Sexual HealthCompletedOvarian CancerUnited States
-
University of WashingtonCompletedOvarian CancerUnited States
-
University of ArizonaCephalonCompletedOvarian CancerUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedOvarian CancerUnited States
-
University of ChicagoCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian CancerUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)UnknownOvarian CancerUnited States
-
Weill Medical College of Cornell UniversityTerminated
-
Sutro Biopharma, Inc.RecruitingOvarian Cancer | Fallopian Tube Cancer | Ovarian Carcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian Carcinoma | Refractory Ovarian Carcinoma | Refractory Fallopian Tube... and other conditionsUnited States
-
Innovation Pharmaceuticals, Inc.Completed
-
Fujirebio Diagnostics, Inc.Completed
-
University of Maryland, College ParkCompleted
-
AstraZenecaCompletedOvarian CancerUnited Arab Emirates
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnOvarian CancerUnited States
-
University of South AlabamaMayo Clinic; Washington University School of Medicine; Tulane University Health... and other collaboratorsCompletedOvarian CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedOvarian CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedOvarian CancerUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.Completed
-
University of PennsylvaniaCompleted
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterKeryx BiopharmaceuticalsCompletedOvarian CancerUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Withdrawn
-
M.D. Anderson Cancer CenterTerminatedOvarian CancerUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompleted
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)WithdrawnOvarian Serous Cystadenocarcinoma | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Ovarian Germ Cell Tumor | Ovarian Papillary Serous Carcinoma | Recurrent Fallopian Tube CancerUnited States
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Brenner Tumor | Stage III Ovarian Epithelial Cancer | Ovarian Mucinous Cystadenocarcinoma | Ovarian Undifferentiated AdenocarcinomaUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Not yet recruitingFallopian Tube Carcinoma | Ovarian Carcinoma | Hereditary Breast and Ovarian Cancer Syndrome | Primary Peritoneal CarcinomaUnited States
-
NCIC Clinical Trials GroupCompletedOvarian CancerUnited States, Canada, United Kingdom
-
University of LouisvilleJames Graham Brown Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterTerminatedOvarian Cancer | Sexual DysfunctionUnited States